Press Releases Novelion Therapeutics Inc. Toronto S.E.

Equities

NVLN

CA67001K2020

Delayed Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-2.92%	-.--%

2020	Novelion Therapeutics Inc. Announces Management Changes	CI
2020	Novelion Therapeutics Inc. Announces Management Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novelion Therapeutics Provides Update on Liquidation Process	20-09-30	GL
Novelion Therapeutics Ceases to be a Reporting Issuer in Canada	20-07-08	GL
Novelion Therapeutics : Provides Update on Liquidation and Claims Process	20-06-15	AQ
Novelion Therapeutics Provides Update on Liquidation and Claims Process	20-06-12	GL
Novelion Therapeutics Confirms Commencement of Voluntary Liquidation	20-01-16	GL
NOVELION THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	20-01-10	AQ
Novelion Therapeutics Announces January 16, 2020 Effective Date for Commencement of Voluntary Liquidation	20-01-09	GL
Novelion Therapeutics : Provides Updates on Voluntary Liquidation and Other Matters	20-01-06	AQ
NOVELION THERAPEUTICS INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	20-01-03	AQ
Novelion Therapeutics Provides Update on Effective Date of Liquidation	19-12-11	GL
Novelion Therapeutics Announces Results of 2019 Annual General Meeting of Shareholders	19-11-05	GL
Novelion Therapeutics Announces Nasdaq Delisting	19-10-08	GL
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters	19-10-03	GL
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders	19-09-11	GL
Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq	19-08-21	GL
Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019	19-08-12	GL
Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition	19-07-16	GL
Novelion Therapeutics Receives Delisting Notifications	19-07-05	GL
Novelion Therapeutics Responds to Whitefort Capital Petition	19-06-24	GL
Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion	19-05-20	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Novelion Therapeutics Inc. Toronto S.E.

Equities

NVLN

CA67001K2020

Press Releases

Filters